2023 September Life Sciences Update

Drug Trials Dominate the Global Clinical Trials Market

› Clinical trials drive real estate demand: › R&D Facilities – Lab space is needed for a variety of stages of drug development, including preclinical testing, formulation development, and clinical sample analysis › M&D Facilities – If a clinical trial is successful, companies may need additional space to produce and distribute the product at scale › Office Facilities – Substantial regulatory requirements often require additional administrative personnel to ensure compliance and successful project management › Phase 3 trials can involve thousands of patients and generally require the most space

The Number of Clinical trials Are Greatest in Markets With the Largest Research Facilities.

Early Phase 1 4%

Phase 4 9%

Phase 1 17%

Other 34%

Drug 38%

Phase 3 23%

Phase 1 | Phase 2

Key Takeaway: Space needs for life science companies can vary depending on the stage and type of clinical trials.

Biological 13%

Phase 2 | Phase 3

Phase 2 32%

Device 15%

Source: Clinicaltrials.gov

25 / CUSHMAN & WAKEFIELD

LIFE SCIENCES SEPTEMBER 2023